newsfilter
← Latest News
GlobeNewswire·

Axovant Gene Therapies Announces Pricing of $65 Million Public Offering

NEW YORK and BASEL, Switzerland, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (Nasdaq: AXGT) ("Axovant") today announced the pricing of its underwritten public offering of...